3
Announcements
Trials
Browse
Landscape
Sponsor
Cancer Type
Plasma cell
161
Lymphoid
109
Other hematologic neoplasm
21
Myeloid
5
Gastrointestinal
3
Dermatologic
3
CNS
3
Sarcoma
2
Classical hematology
2
Thoracic
1
Other solid neoplasm
1
Gynecologic
1
Genitourinary
1
Breast
1
Interventions
lutetium Lu 177 dotatate
29
Magnetic Resonance Spectroscopy
15
Everolimus
10
pembrolizumab
9
Specimen Handling
9
cabozantinib
7
Nivolumab
7
Lutetium-177
6
surufatinib
5
lenvatinib
5
Octreotide
5
Capecitabine
5
177Lu-octreotide, DOTA(0)-Tyr(3)-
5
olaparib
4
lanreotide
4
gallium Ga 68 dotatate
4
amino-acid, glucose, and electrolyte solution
4
X-Rays
4
Lutetium
4
Ipilimumab
4
Injections
4
Fluorodeoxyglucose F18
4
copper dotatate CU-64
3
atezolizumab
3
Temozolomide
3
Ga(III)-DOTATOC
3
Cyclophosphamide
3
Carboplatin
3
pasireotide
2
fludarabine phosphate
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lenalidomide
×
NET
×
1 year
×
Clear all
No trials found.